STOCK TITAN

Insider plans sale of 40,976 STIM (STIM) shares under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

STIM filed a notice of proposed sale of restricted securities under Rule 144. The filing covers the planned sale of 40,976 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ around February 10, 2026, with an aggregate market value of $63,398.07.

These shares were acquired on February 5, 2026 through restricted stock vesting from the issuer as compensation. Shares outstanding were 68,485,922. The seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing disclose for STIM?

The Form 144 discloses a planned sale of 40,976 shares of STIM common stock under Rule 144. The shares are to be sold through Fidelity Brokerage Services on NASDAQ, with an indicated aggregate market value of $63,398.07 at the time of the notice.

How many STIM shares are proposed to be sold and on which exchange?

The notice covers a proposed sale of 40,976 shares of STIM common stock. The filing lists Fidelity Brokerage Services as broker and identifies NASDAQ as the securities exchange where the shares are expected to be sold around February 10, 2026.

How and when were the STIM shares being sold under Form 144 acquired?

The 40,976 STIM common shares were acquired on February 5, 2026 via restricted stock vesting from the issuer. The filing describes the acquisition as compensation, indicating the shares were granted by the company rather than purchased for cash in the open market.

What is the aggregate market value of the STIM shares in this Form 144?

The Form 144 lists an aggregate market value of $63,398.07 for the 40,976 STIM common shares to be sold. This value reflects the market price at the time of the notice and is used to quantify the size of the proposed Rule 144 transaction.

How many STIM shares of the same class are outstanding?

The filing states that 68,485,922 shares of the same class of STIM common stock are outstanding. This figure provides context for the size of the proposed 40,976-share sale relative to the issuer’s total outstanding common shares at the time of the notice.

What representation does the seller make about STIM’s information in this Form 144?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about STIM’s current or prospective operations that has not been publicly disclosed, as required by the Rule 144 notice language in the form.
Neuronetics

NASDAQ:STIM

STIM Rankings

STIM Latest News

STIM Latest SEC Filings

STIM Stock Data

99.99M
34.32M
9.44%
59.08%
8.87%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MALVERN